BPC-157 Peptide Therapy Due to its mode of action, the BPC-157 peptide acts as a tissue-elasticizing agent, leading to strengthening of the pelvic floor muscles
The name reflects the context of its discovery, not a confirmed action in humans in the literature, DSIP remains a subject of research, and its mechanism has not been unambiguously explained (there is no clearly identified receptor)
Studies investigating BPC-157 brain injury models, such as traumatic brain injury (TBI) in rats, have found that its administration can reduce neuronal damage, mitigate cerebral edema, and improve functional outcomes
Thomas, P., Pang, Y., Dong, J
Its gene PDHA2 is located on chromosome 4 having length of 1383 bp/460 aa [7, 8] Whereas the alpha 2 subunit is designated asPDH E1-A type1 (i.e.) synonym PHE1A
You can explore our full collection of peptides to see the breadth of research possibilities